Tushar Date

636 total citations
22 papers, 493 citations indexed

About

Tushar Date is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Tushar Date has authored 22 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Biomaterials and 6 papers in Pharmaceutical Science. Recurrent topics in Tushar Date's work include Nanoparticle-Based Drug Delivery (7 papers), Advancements in Transdermal Drug Delivery (4 papers) and RNA Interference and Gene Delivery (4 papers). Tushar Date is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Advancements in Transdermal Drug Delivery (4 papers) and RNA Interference and Gene Delivery (4 papers). Tushar Date collaborates with scholars based in India, United States and Australia. Tushar Date's co-authors include Sanyog Jain, Kaushik Kuche, Rohan Ghadi, Deepak Chitkara, Dasharath Chaudhari, Ram I. Mahato, Anupama Mittal, Kaushik Thanki, Sameer S. Katiyar and Saurabh Sharma and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and International Journal of Biological Macromolecules.

In The Last Decade

Tushar Date

21 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tushar Date India 14 201 190 134 103 64 22 493
Yinglan Yu China 13 180 0.9× 159 0.8× 124 0.9× 99 1.0× 52 0.8× 24 477
Rohan Lalani India 16 263 1.3× 221 1.2× 160 1.2× 108 1.0× 87 1.4× 21 605
Samira Naderinezhad Iran 9 297 1.5× 231 1.2× 152 1.1× 145 1.4× 55 0.9× 19 651
Shruti Rawal India 14 169 0.8× 222 1.2× 129 1.0× 159 1.5× 53 0.8× 22 514
Gamze Varan Türkiye 11 134 0.7× 184 1.0× 122 0.9× 89 0.9× 63 1.0× 19 405
Valamla Bhavana India 16 160 0.8× 226 1.2× 216 1.6× 151 1.5× 44 0.7× 27 712
Haijun Zhong China 6 189 0.9× 213 1.1× 76 0.6× 141 1.4× 33 0.5× 7 476
Beatriz García-Pinel Spain 9 228 1.1× 244 1.3× 86 0.6× 201 2.0× 58 0.9× 10 549
Xiaolong Tang China 14 195 1.0× 195 1.0× 61 0.5× 139 1.3× 66 1.0× 19 515
Ruchit Trivedi United States 9 218 1.1× 170 0.9× 126 0.9× 93 0.9× 51 0.8× 10 632

Countries citing papers authored by Tushar Date

Since Specialization
Citations

This map shows the geographic impact of Tushar Date's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tushar Date with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tushar Date more than expected).

Fields of papers citing papers by Tushar Date

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tushar Date. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tushar Date. The network helps show where Tushar Date may publish in the future.

Co-authorship network of co-authors of Tushar Date

This figure shows the co-authorship network connecting the top 25 collaborators of Tushar Date. A scholar is included among the top collaborators of Tushar Date based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tushar Date. Tushar Date is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghadi, Rohan, Kaushik Kuche, Tushar Date, et al.. (2024). Advancing apoptosis induction in triple negative breast cancer: Empowering treatment with tyrosine-stapled mixed micelles of lapatinib. Journal of Molecular Liquids. 401. 124635–124635. 5 indexed citations
2.
Date, Tushar, Oly Katari, Kaushik Kuche, Dasharath Chaudhari, & Sanyog Jain. (2024). Launching triple-hit chemo attack on TNBC through nanoparticle-mediated codelivery of cisplatin-chlorambucil conjugate and venetoclax. International Journal of Pharmaceutics. 667(Pt A). 124890–124890.
3.
Ghadi, Rohan, et al.. (2024). Unlocking apoptosis in triple negative breast cancer: Harnessing “glutamine trap” to amplify the efficacy of lapatinib-loaded mixed micelles. Biomaterials Advances. 159. 213822–213822. 10 indexed citations
4.
Jain, Sanyog, Reena Sharma, Rohan Ghadi, et al.. (2023). Exploring the therapeutic potential of functional excipient-based nanoemulgel of fluticasone propionate for the management of psoriasis. Journal of Drug Delivery Science and Technology. 84. 104435–104435. 9 indexed citations
5.
6.
Ghadi, Rohan, et al.. (2023). Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer. International Journal of Pharmaceutics. 648. 123570–123570. 23 indexed citations
7.
Kuche, Kaushik, et al.. (2023). Synergistic anticancer therapy via ferroptosis using modified bovine serum albumin nanoparticles loaded with sorafenib and simvastatin. International Journal of Biological Macromolecules. 253(Pt 8). 127254–127254. 18 indexed citations
8.
Chaudhari, Dasharath, et al.. (2022). Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer. Drug Delivery and Translational Research. 13(4). 1074–1087. 30 indexed citations
9.
Date, Tushar, Kaushik Kuche, Rohan Ghadi, Pradeep Kumar, & Sanyog Jain. (2022). Understanding the Role of Axial Ligands in Modulating the Biopharmaceutical Outcomes of Cisplatin(IV) Derivatives. Molecular Pharmaceutics. 19(5). 1325–1337. 8 indexed citations
10.
Jain, Sanyog, Reena Sharma, Rohan Ghadi, et al.. (2022). Self-nanoemulsifying formulation for oral delivery of sildenafil: effect on physicochemical attributes and in vivo pharmacokinetics. Drug Delivery and Translational Research. 13(3). 839–851. 9 indexed citations
11.
Chaudhari, Dasharath, Oly Katari, Rohan Ghadi, et al.. (2022). Unfolding the Potency of Adenosine in Targeting Triple Negative Breast Cancer via Paclitaxel-Incorporated pH-Responsive Stealth Liposomes. ACS Biomaterials Science & Engineering. 8(8). 3473–3484. 22 indexed citations
12.
Kuche, Kaushik, Dasharath Chaudhari, Rohan Ghadi, et al.. (2022). Supersaturable self-emulsifying drug delivery system: A strategy for improving the loading and oral bioavailability of quercetin. Journal of Drug Delivery Science and Technology. 71. 103289–103289. 28 indexed citations
13.
Ghadi, Rohan, Kaushik Kuche, Tushar Date, et al.. (2021). Green surfactant-dendrimer aggreplexes: An ingenious way to launch dual attack on arch-enemy cancer. Colloids and Surfaces B Biointerfaces. 204. 111821–111821. 6 indexed citations
14.
Thanki, Kaushik, Tushar Date, & Sanyog Jain. (2021). Enabling Oral Amphotericin B Delivery by Merging the Benefits of Prodrug Approach and Nanocarrier-Mediated Drug Delivery. ACS Biomaterials Science & Engineering. 9(6). 2879–2890. 14 indexed citations
15.
16.
Date, Tushar, et al.. (2019). Drug–Lipid Conjugates for Enhanced Oral Drug Delivery. AAPS PharmSciTech. 20(2). 41–41. 28 indexed citations
17.
Thanki, Kaushik, Tushar Date, & Sanyog Jain. (2019). Improved Oral Bioavailability and Gastrointestinal Stability of Amphotericin B through Fatty Acid Conjugation Approach. Molecular Pharmaceutics. 16(11). 4519–4529. 25 indexed citations
18.
Jain, Sanyog, et al.. (2019). Mechanistic Insights into High Permeation Vesicle-Mediated Synergistic Enhancement of Transdermal Drug Permeation. Nanomedicine. 14(16). 2227–2241. 6 indexed citations
19.
Sharma, Saurabh, et al.. (2018). Cholesterol and Morpholine Grafted Cationic Amphiphilic Copolymers for miRNA-34a Delivery. Molecular Pharmaceutics. 15(6). 2391–2402. 36 indexed citations
20.
Date, Tushar, et al.. (2017). Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics. Journal of Controlled Release. 271. 60–73. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yinglan Yu Breakdown of academic impact, for papers by Rohan Lalani Breakdown of academic impact, for papers by Samira Naderinezhad Breakdown of academic impact, for papers by Shruti Rawal Breakdown of academic impact, for papers by Gamze Varan Breakdown of academic impact, for papers by Valamla Bhavana Breakdown of academic impact, for papers by Haijun Zhong Breakdown of academic impact, for papers by Beatriz García-Pinel Breakdown of academic impact, for papers by Xiaolong Tang Breakdown of academic impact, for papers by Ruchit Trivedi
Rankless by CCL
2026